Company: KNRX
Filing Date: 2025-09-30
Form Type: 424B4
Source: 0001493152-25-016175
Chunk: 177

Company: KNOREX LTD.
Filing Date: 2025-09-30
Form: 424B4
Chunk 177
---
 will reimburse the Representative for accountable out-of-pocket expenses not to exceed US$200,000. Such accountable out-of-pocket expenses include, but not limited to travel, due diligence expenses, reasonable fees and expenses of its legal counsel, roadshow and background check on the Company’s principals in connection with the performance of the Representative’s services. In the event that the engagement terminates prior to the completion of the Offering or upon completion of the Offering, the Company agrees to pay promptly in cash any unreimbursed expenses that have accrued as of such date. At the closing of the Offering, we will reimburse the Representative one percent (1%) of the actual amount of the Offering as non-accountable expense of the Offering.

We estimate that the total expenses payable by us in connection with the offering, other than the underwriting discounts, will be approximately US$1,500,000, including a maximum aggregate reimbursement of US$200,000 of Representative’s accountable expenses.

The Representative intends to offer our Class A Ordinary Shares to a number of prospective institutional and retail investors in states in which we are permitted to offer our Class A Ordinary Shares. Concurrently with or as soon as practicable after the filing of this registration statement with the SEC, the Company shall make all necessary state “blue sky” securities law filings with respect to the Class A Ordinary Shares to be sold in this offering (including the over-allotment shares). We and the Representative will cooperate in obtaining the necessary approvals and qualifications in such states as the Representative deems necessary and/or desirable.

The foregoing does not purport to be a complete statement of the terms and conditions of the underwriting agreement and subscription agreement. A form of the underwriting agreement will be included as an exhibit to the registration statement of which this prospectus forms a part.

| 93 |

Right of First Refusal

If within the 18-month period following consummation of this offering, we or any of our subsidiaries (i) decides to finance or refinance any indebtedness using a manager or agent, the Representative (or any affiliate designated by the Representative) shall have the right to act as sole investment banker, sole book-runner, sole placement agent and/or sole advisor, at the Representative’s sole discretion, with respect to such financing or refinancing; or (ii) decides to raise funds by means of an equity offering or a private placement of equity or debt securities using an underwriter or placement agent, the Representative (or any affiliate designated by the Representative) shall have the right to act as exclusive financial advisor,